Company: OSRH
Filing Date: 2025-01-24
Form Type: S-4/A
Source: 0001213900-25-006139
Chunk: 62

Company: OSR Holdings, Inc.
Filing Date: 2025-01-24
Form: S-4/A
Chunk 62
---
 Business Combination Proposal, whether or not you plan to attend such special meeting, we urge you to read this entire proxy statement/prospectus (including the Annexes) carefully, including the section entitled “Risk Factors” beginning on page 50. See also the section entitled “Where You Can Find More Information.” Unless otherwise specified, all share amounts and share calculations: (i) assume no exercise of redemption rights by our public stockholders, (ii) do not include (a) any warrants to purchase BLAC Common Stock that will be outstanding following the Business Combination, (b) any rights converted into shares of BLAC Common Stock upon the consummation of the Business Combination, or (c) any equity awards that may be issued under our proposed Omnibus Plan following the Business Combination. Certain figures included in this section have been rounded for ease of presentation and, as a result, percentages may not sum to 100%. Parties to the Business Combination Bellevue Life Sciences Acquisition Corp. We are a Delaware corporation incorporated on February 25, 2020 for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. Our securities are traded on Nasdaq under the ticker symbols “BLAC,” “BLACU,” “BLACW,” and “BLACR.” Following the Business Combination, we expect to change our name to OSR Holdings, Inc. BLAC has applied for listing, to be effective at the time of the Business Combination, of New OSR Holdings common stock (“ New OSR Holdings Common Stock”) and warrants on Nasdaq under the proposed symbols “OSRH” and “OSRHW,” respectively. The mailing address of the Company’s principal executive office is 10900 NE 4 thStreet, Suite 2300, Bellevue, Washington 98004 and the telephone number of the Company’s principal executive office is (425) 635 -7700. OSR Holdings Co., Ltd. OSR Holdings, a corporation organized under the laws of the Republic of Korea, is a global healthcare company, dedicated to advancing healthcare outcomes and improving the quality of life for people and their families. OSR Holdings aims to build and develop a robust portfolio of innovative and potentially transformative therapies and healthcare solutions. OSR Holdings current operating businesses (through our three wholly -ownedsubsidiaries) include (i) developing oral immunotherapies for the treatment of cancer, (ii) developing design -augmentedbiolog